Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Mount Nebo Capital | 24,95 | 24,95 | 2025-03-04 |
| Flexmedical Solutions Limited | 6,32 | 6,32 | 2025-02-17 |
| UNITY Innovation Alliance AG | 5,17 | 5,17 | 2025-03-04 |
| Henrik Ruö Jensen | 3,65 | 3,65 | 2025-03-27 |
| Michael Kantor | 3,41 | 3,41 | 2025-03-27 |
| Avanza Pension | 2,85 | 2,85 | 2025-03-27 |
| Nordnet Pensionsförsäkring | 2,49 | 2,49 | 2025-03-27 |
| Per Robert Anderson | 1,85 | 1,85 | 2025-03-27 |
| Olof Hedin | 1,12 | 1,12 | 2025-03-27 |
| Johann Bech Vedsmand | 0,98 | 0,98 | 2025-03-27 |
2025-08-20 Delårsrapport 2025-Q2
2025-11-12 Delårsrapport 2025-Q3
